Electroretinogram and Retinal Vascular Changes After Cataract Surgery
NCT ID: NCT05871034
Last Updated: 2023-05-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2023-05-15
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cataract Surgery Combined With Endoscopic Goniosynechialysis for Advanced Primary Angle Closure Glaucoma
NCT03686072
Anterior Segment Changes by Optical Coherence Tomography (OCT) in Phaco- Trabeculectomy
NCT03626675
Correlation Between Optical Coherence Tomography Angiography and Photopic Negative Response in Patients With Glaucoma
NCT05104294
OCTA in Patients With Primary Open-angle Glaucoma
NCT06214676
Visual Field Changes and OCT Angiographic Chorioretinal Changes in Patients With Primary Open Angle Glaucoma
NCT06978101
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
* Location: Ophthalmology department, Sohag university hospital. In this prospective study, aiming to investigate Optical coherence tomography angiography and electrophysiological changes after cataract surgery in normal and patients with POAG with cataract 1 day before operation, 1 week and 3 months postoperatively.
* Methodology The study will include 50 patients with primary open angle glaucoma associated with cataract and 50 patients have cataract without glaucoma.
Preoperative and postoperative evaluation:
All patients will be subjected to the following:
* History taking including age, gender, family history, systemic diseases, previous medications or ophthalmic surgery.
* Detailed ophthalmological examination including: Uncorrected visual acuity (UCVA), best corrected visual acuity (BCVA) by Snellen's fraction and converted into logarithm of the minimal angle of resolution LogMAR, refraction, keratometry, slit lamp biomicroscopy for anterior segment, IOP measurement by applanation tonometer, and posterior segment (Fundus) examination.
* Examination of the angle of anterior chamber by goniolens.
* OCTA disc and macula
* Pattern ERG and multifocal ERG
Surgical techniques:
Patients will be subdivided into two groups:
Group (A): normal Patients will undergo standard phacoemulsification surgery. Group (B): Patients with POAG will undergo standard phacoemulsification surgery.
\* phaco technology by using (WHITESTAR SIGNATURE PRO, Abbott, USA)
* OCT angiography will be done by (Optovue, Inc., Fremont, California, USA).
* Electrophysiology will be done by (Roland consult Retimap, Germany)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Control group who have cataract without Open Angle glaucoma Will under go phacoemulsification cataract surgery
phacoemulsification
cataract extraction
Open Angle glaucoma group
patients who have cataract and Open Angle glaucoma Will undergo phacoemulsification cataract surgery
phacoemulsification
cataract extraction
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
phacoemulsification
cataract extraction
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with primary open angle diagnosed for at least 2 years with glaucoma treatment associated with cataract (N1-N2).
Exclusion Criteria
* Previous intraocular surgery.
* Associated ocular or intra ocular inflammation
* Previous history of eye trauma.
* Associated intraocular pathology
45 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Sohag University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shorouq Abdelrahman Hassan
Assistant lecturer
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
shorouq abdelrahman
Role: PRINCIPAL_INVESTIGATOR
Sohag University
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
alaa mahmoud
Role: CONTACT
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SAHASSAN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.